XNAS · Laboratory Analytical Instruments · S&P 500
$5.15
-$0.24 (-4.45%) today
Open $5.39 High $5.58 Low $5.11 Vol 162K Avg $5.25
Find similar stocks by technical condition — S&P 500 universe
| Symbol | Company Name | Exchange | Currency | Category |
|---|---|---|---|---|
| NEWP | New Pacific Metals Corp. | XASE | USD | - |
| IAG | IAMGold Corporation | XNYS | USD | - |
| BHST | BioHarvest Sciences Inc. Common Stock | XNAS | USD | - |
| BLDP | Ballard Power Systems Inc. | XNAS | USD | - |
| VFS | VinFast Auto Ltd. Ordinary Shares | XNAS | USD | - |
| CHY | Calamos Convertible and High Income Fund | XNAS | USD | - |
| AEC | Anfield Energy Inc. Common Shares | XNAS | USD | - |
| GCDT | Green Circle Decarbonize Technology Limited | XASE | USD | - |
| OXLC | Oxford Lane Capital Corp. | XNAS | USD | - |
| DTSS | Datasea Intelligent Technology Ltd. Class A Ordinary Shares | XNAS | USD | - |
52-week price range
Price is 0.0% above its 52-week low and 0.0% below its 52-week high. Trading in the lower half of its annual range — closer to the floor than the ceiling.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.